Alfasigma USA Growth, Revenue, Number of Employees and Funding

Overview

Location:
Covington, LA USA
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Alfasigma USA's estimated revenue is currently $21.6M per year.
  • Alfasigma USA's estimated revenue per employee is $200000

Employee Data

  • Alfasigma USA has 108 Employees.
  • Alfasigma USA grew their employee count by 26% last year.
  • Alfasigma USA currently has 7 job openings.

Executive Contacts

NameTitle
Elaine Ludovico Director Commercial Finance
Jason KimballRegional Sales Director - WEST US
Madhusudan VudathalaVice President,Head of Manufacturing operations
Harold KochEVP & CSO
Nikki BlandDirector of Facilites
Robert TyburskiDirector Regulatory Compliance
Jim HendrySVP, HR
Steve ShuttleworthDirector of IT and PMO
Jim CurrieDirector of Marketing Services
Bruce HoltDirector Sales Operations and Analytics

What Is Alfasigma USA?

Pamlab, formerly part of Nestle Health Sciences, is now Alfasigma USA. Alfasigma USA, Inc. distributes a portfolio of prescription nutritional products to help individuals who are suffering from GI disorders (VSL#3®), major depressive disorder (Deplin®), diabetic peripheral neuropathy (Metanx®), and mild cognitive impairment (CerefolinNAC®). Through the company's commitment to improving patients health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Alfasigma USA has corporate headquarters in Covington, LA and a newly opened commercial hub in Bedminster, NJ. Discover Alfasigma USA at http://www.alfasigmausa.com.

keywords:N/A

108

Number of Employees

$21.6M

Revenue (est)

7

Current Jobs

26%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Southern Script...
$26.1M4231%
Alfasigma USA
$21.6M10826%

Alfasigma USA News

09/03/2019 - Alfasigma USA Announces ZELNORM™ (tegaserod) Now ...

Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical ...

09/08/2019 - Alfasigma brings Zelnorm back to US market

The US subsidiary of Italian drugmaker Alfasigma yesterday announced that Zelnorm (tegaserod) is now available in the USA as a prescription ...

09/03/2019 - Global Irritable Bowel Syndrome (IBS) Market Size 2019 ...

... market are Allergan Plc (Ireland), Sucampo Pharmaceuticals (U.S.), ... Sebela Pharmaceuticals (Ireland), Probi (Sweden), Alfasigma USA, ...